[go: up one dir, main page]

GB2452363B - Novel fish pathogen - Google Patents

Novel fish pathogen

Info

Publication number
GB2452363B
GB2452363B GB0811812.7A GB0811812A GB2452363B GB 2452363 B GB2452363 B GB 2452363B GB 0811812 A GB0811812 A GB 0811812A GB 2452363 B GB2452363 B GB 2452363B
Authority
GB
United Kingdom
Prior art keywords
novel fish
fish pathogen
pathogen
novel
fish
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB0811812.7A
Other versions
GB2452363A8 (en
GB0811812D0 (en
GB2452363A (en
Inventor
Svein Alexandersen
Trygve Meum Eliassen
Inge Tom Solbakk
Marit Rode
Marianne Froystad-Saugen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaq AS
Original Assignee
Pharmaq AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaq AS filed Critical Pharmaq AS
Publication of GB0811812D0 publication Critical patent/GB0811812D0/en
Publication of GB2452363A publication Critical patent/GB2452363A/en
Publication of GB2452363A8 publication Critical patent/GB2452363A8/en
Application granted granted Critical
Publication of GB2452363B publication Critical patent/GB2452363B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/06—Inactivation or attenuation by chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB0811812.7A 2007-06-28 2008-06-27 Novel fish pathogen Active GB2452363B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200700941 2007-06-28

Publications (4)

Publication Number Publication Date
GB0811812D0 GB0811812D0 (en) 2008-07-30
GB2452363A GB2452363A (en) 2009-03-04
GB2452363A8 GB2452363A8 (en) 2009-03-18
GB2452363B true GB2452363B (en) 2012-08-08

Family

ID=38472894

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0811812.7A Active GB2452363B (en) 2007-06-28 2008-06-27 Novel fish pathogen

Country Status (4)

Country Link
CA (1) CA2634144C (en)
CL (1) CL2008001910A1 (en)
GB (1) GB2452363B (en)
NO (1) NO346433B1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2560985B1 (en) 2010-04-21 2016-06-29 Pharmaq AS Nucleic acid sequences of a fish virus and the use thereof
CA2817933A1 (en) 2010-11-15 2012-05-24 Pharmaq As New salmon calicivirus isolate
NO347765B1 (en) * 2012-11-01 2024-03-18 Ewos Innovation As Feed composition for fish
CN109358194A (en) * 2018-09-29 2019-02-19 中国海洋大学 Indirect competitive enzyme-linked immunosorbent assay for hyperglycemic hormones in Litopenaeus vannamei
CN113122510A (en) * 2021-04-12 2021-07-16 中国水产科学研究院黑龙江水产研究所 Infectious hematopoietic necrosis vaccine and method for amplifying virus thereof on phoxinus fatigani muscle cells

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005121325A1 (en) * 2004-06-11 2005-12-22 Pharmaq As Heart and skeletal muscle inflammation (hsmi) virus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005121325A1 (en) * 2004-06-11 2005-12-22 Pharmaq As Heart and skeletal muscle inflammation (hsmi) virus

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Diseases of Aquatic Organisms, Vol. 29, No. 2, 1997, S Grotmol et al., "Detection of a nodavirus-like agent in heart tissue from reared Atlantic salmon Salmo salar suffering from cardiac myopathy syndrome (CMS)", pages 79-84. *
Diseases of Aquatic Organisms, Vol. 56, No. 1, Aug 2003, T Poppe, et al., "First description of cardiomyopathy syndrome (CMS)-related lesions in wild Atlantic salmon Salmo salar in Norway.", pages 87-88. *
Diseases of Aquatic Organisms, Vol. 59, No. 3, June 2004, RT Kongtorp, et al., "Pathology of heart and skeletal muscle inflammation (HSMI) in farmed Atlantic salmon Salmo salar", pages 217-224. *
Diseases of Aquatic Organisms, Vol. 66, No. 2, Sep 2005, K Hodneland, et al., "New subtype of salmonid alphavirus (SAV), Togaviridae, from Atlantic salmon Salmo salar and rainbow trout Oncorhynchus mykiss in Norway", pages 113-120 *
Journal of Fish Diseases, Vol. 30, No. 9, Sep 2007, MF McLoughlin, et al., "Alphavirus infections in salmonids - a review", pages 511-531. *
Report for the Scottish Aquaculture Research Forum, November 2007, "The aetiology and epidemiology of PD, HMSI, and CMS in Scotland", available online from http://www.sarf.org.uk/Project%20Final%20Reports/SARF015%20Final%20Report.pdf [accessed 12 December 2008]. *

Also Published As

Publication number Publication date
CA2634144A1 (en) 2008-12-28
NO20082869L (en) 2008-12-29
GB2452363A8 (en) 2009-03-18
GB0811812D0 (en) 2008-07-30
CA2634144C (en) 2018-01-02
CL2008001910A1 (en) 2009-08-07
GB2452363A (en) 2009-03-04
NO346433B1 (en) 2022-08-08

Similar Documents

Publication Publication Date Title
IL202616A0 (en) Substituted imidazoheterocycles
ZA201001683B (en) Substituted piperidino-dihydrothienopyrimidines
EP2196087A4 (en) Lure
AP2010005314A0 (en) Nanodispersian
ZA200904941B (en) Novel methods
GB0724258D0 (en) Novel combinations
GB2452363B (en) Novel fish pathogen
IL200965A0 (en) Substituted tetrahydropyrroloquinolines
GB0723387D0 (en) Improved dehumldifier
EP2105070A4 (en) Chopsticks
EP2161998A4 (en) Novel methods
GB0701694D0 (en) Fishing scope
GB0722342D0 (en) Bait
AU3595P (en) Goldust Strobilanthes anisophyllus
AU3642P (en) TAS100 Dianella tasmanica
AU3606P (en) Jaywick xTriticosecale
AU3613P (en) LS005A01 Leucospermum cuneiforme
AU3646P (en) TAS300 Dianella tasmanica
HK1108802A2 (en) Multi-functional timer
GB0721702D0 (en) Hydrogienic globaltechnology limited
HK1101014A2 (en) Chopsticks
GB0724415D0 (en) CV-kinisis II
ZA201000435B (en) Substituted imidazoheterocycles
GB0714068D0 (en) No riveal
GB0713975D0 (en) No Riveal

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20130815 AND 20130821